Advertisements


Novo Nordisk to initiate Phase 3a trial in obesity with semaglutide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Novo Nordisk Phase 2 ziltivekimab trial met endpoints in kidney disease

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2021

Novo Nordisk reports results of PIONEER 3 trial of oral semaglutide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2019

Novo Nordisk says Pioneer 2 Phase 3a trial achieved primary objective

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

Novo Nordisk"s (NVO) Oral Ozempic Positive in Diabetes Study

Novo Nordisk (NVO) announces positive headline results of two phase III studies PIONEER oral formulation of Ozempic (semaglutide) as a treatment for adults with type II diabetes. Novo Nordisk NVO announced positive headline results o.....»»

Category: personnelSource: nytJun 21st, 2018

Novo Nordisk says oral semaglutide trial achieves primary objective

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Novo Nordisk says PIONEER 5 trial of Oral semaglutide achieved primary objective

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 20th, 2018

Novo Nordisk says semaglutide trial achieved objective under primary approach

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 26th, 2018

Moleculin Biotech cleared to initiate Phase 1b/2 trial evaluating Annamycin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

        - First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis' Anti-BCMA Agent for the Treatment of Multiple Myeloma - - On Track to Initiate AL102 Phase 2/3 Pivotal Trial for the Treatment of.....»»

Category: earningsSource: benzingaMay 14th, 2021

Brii Bio, Vir, VBI Vaccines initiate Phase 2 trial of BRII-835/BRII-179

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Novo Nordisk reports full results of STEP 4 trial were presented at ENDO meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 23rd, 2021

Novo Nordisk discloses FDA Refusal to File letter for semaglutide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 22nd, 2021

Arbutus receives regulatory approval to initiate Phase 1a/1b trial of AB-836

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 16th, 2021

Natera and Genentech initiate Phase 3 trial of Signatera test

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 10th, 2021

Kronos Bio to initiate Phase 3 trial of entospletinib in mid-2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 4th, 2021

Assembly Biosciences, Arbutus initiate Phase 2 trial of combination therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2021

Adaptimmune to initiate Phase 2 SURPASS-2 trial with ADP-A2M4CD8

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2021

Lixte Biotechnology, City of Hope to initiate Phase 1b trial of LB-100

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Denali says Sanofi plans to initiate Phase 2 trial of DNL758 in early 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2021

Novo Nordisk files for EU approval of once-weekly semaglutide to treat T2D

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 29th, 2020